MedPath

Paired Assessment of Two Electromyographic Neuromuscular Monitors: Stimpod NMX450X Versus Datex-Ohmeda E-NMT

Not Applicable
Recruiting
Conditions
Neuromuscular Manifestations
Registration Number
NCT04931901
Lead Sponsor
Universitair Ziekenhuis Brussel
Brief Summary

After anesthesia is induced, 2 EMG TOFF devices will be placed on the patients arms, one on the right arm, the other on the left. There will be a randomization per dominant hand and nondominant hand for the placing of the devices. The devices are the Stimpod NMX450X and the Datex-Ohmeda E-NMT.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Adult patients (18 years old and above)
  • undergoing General Anaesthesia for noncardiac surgery requiring the use of a neuromuscular blocking agent.
Exclusion Criteria
  • Use of different types of neuromuscular blocking agents for the same patient within the same surgical procedure.
  • Known Neuromuscular diseases/syndromes judged to condition accurate neuromuscular monitoring.
  • Known acute or chronic hepatic disease.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
TOF-ratio (percentage)Up until 120 minutes

TOF = Train-of-four. TOF-ratio is the ratio of the fourth muscle response to the first one. This is used to assess neuromuscular transmission. TOF% indicates fade in non-depolarizing block. We are comparing the calculated TOF ratio of the stimpod NMX to the datex-ohmeda E-NMT

Secondary Outcome Measures
NameTimeMethod
TOF-count (absolute number)Up until 120 minutes.

TOF count is the actual number of detected muscle responses. The number that is used to calculate the percentage (TOF-ratio). When the TOF count drops below 4 responses, then the TOF% cannot be calculated. We are comparing the detected muscle responses of the stimpod NMX to the datex-ohmeda E-NMT

Trial Locations

Locations (1)

UZ Brussel

🇧🇪

Jette, Brussel, Belgium

UZ Brussel
🇧🇪Jette, Brussel, Belgium
Evelien Vandeurzen, Biomedical Sciences
Contact
024749237
evelien.vandeurzen@uzbrussel.be
Hugo Carvalho, MD
Principal Investigator
Panagiotis Flamée, MD
Sub Investigator
Michael Verdonck, MD
Sub Investigator
Gregory Van Stighel, MD
Sub Investigator
Philippe Kinnaer, MD
Sub Investigator
William Alliet, MD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.